Literature DB >> 19620431

CT and PET/CT findings of T-cell lymphoma.

Hansel J Otero1, Jyothi P Jagannathan, Luciano M Prevedello, Ciaran J Johnston, Nikhil H Ramaiya, Annick D Van den Abbeele, Pamela J DiPiro.   

Abstract

OBJECTIVE: The purpose of this study was to describe the extranodal features of T-cell lymphoma at CT and PET/CT.
CONCLUSION: The extranodal features of T-cell lymphoma are not specific and usually cannot be used to differentiate T-cell lymphoma from other aggressive types of lymphoma. Noncutaneous subtypes frequently manifest with visceral involvement. The goal of CT in initial staging is to exclude visceral involvement. Evidence on the utility of PET/CT is promising, showing high diagnostic value in evaluation of occult disease and treatment response, but the role of PET/CT is evolving.

Entities:  

Mesh:

Year:  2009        PMID: 19620431     DOI: 10.2214/AJR.08.1398

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  13 in total

1.  Anaplastic cutaneous lymphoma mimicking an infection.

Authors:  Luciana Barbosa; Manuel João Brito; Inês Balaco; Maria José Noruegas
Journal:  J Radiol Case Rep       Date:  2014-03-01

Review 2.  Subcutaneous panniculitis-like T-cell lymphoma: MRI features and literature review.

Authors:  Benjamin D Levine; Leanne L Seeger; Aaron W James; Kambiz Motamedi
Journal:  Skeletal Radiol       Date:  2014-04-10       Impact factor: 2.199

3.  Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma.

Authors:  Cinzia Pellegrini; Lisa Argnani; Alessandro Broccoli; Vittorio Stefoni; Enrico Derenzini; Letizia Gandolfi; Beatrice Casadei; Roberto Maglie; Stefano Pileri; Pier Luigi Zinzani
Journal:  Oncologist       Date:  2014-05-28

Review 4.  Imaging of Abdominal Wall Masses, Masslike Lesions, and Diffuse Processes.

Authors:  David H Ballard; Parisa Mazaheri; Daniel C Oppenheimer; Meghan G Lubner; Christine O Menias; Perry J Pickhardt; William D Middleton; Vincent M Mellnick
Journal:  Radiographics       Date:  2020-04-24       Impact factor: 5.333

5.  Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

Authors:  Sally F Barrington; N George Mikhaeel; Lale Kostakoglu; Michel Meignan; Martin Hutchings; Stefan P Müeller; Lawrence H Schwartz; Emanuele Zucca; Richard I Fisher; Judith Trotman; Otto S Hoekstra; Rodney J Hicks; Michael J O'Doherty; Roland Hustinx; Alberto Biggi; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

6.  Composite Cutaneous Lymphoma (Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorder) in a Patient with Rheumatoid Arthritis Treated with Methotrexate: Staging and Evaluation of Response to Therapy with 18F-FDG PET/CT.

Authors:  William Makis; Anthony Ciarallo; Beatrice Wang; Milene Gonzalez-Verdecia; Stephan Probst
Journal:  Nucl Med Mol Imaging       Date:  2016-12-19

7.  Relapsed angioimmunoblastic T-cell lymphoma with large pericardial effusion.

Authors:  Rahul Sawhney; Randy D Volkmer; Barry Cooper
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-10-25

8.  18F-FDG PET/CT findings in hepatosplenic Gamma-Delta T-cell lymphoma: case reports and review of the literature.

Authors:  Michael W Cho; Bennett B Chin
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

9.  18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma.

Authors:  Carla Casulo; Heiko Schöder; John Feeney; Remy Lim; Jocelyn Maragulia; Andrew D Zelenetz; Steven Horwitz
Journal:  Leuk Lymphoma       Date:  2013-03-04

Review 10.  T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes.

Authors:  Hye Sun Park; Lacey McIntosh; Marta Braschi-Amirfarzan; Atul B Shinagare; Katherine M Krajewski
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.